Rituximab for Treatment of Pediatric CNS Inflammatory Disorders
Jeffrey M. Gelfand, MD, MAS
Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review
Adrienne Stevens, clinical research manager1, Larissa Shamseer, PhD candidate12, Erica Weinstein, medical student3, Fatemeh Yazdi, senior clinical research associate1, Lucy Turner, biostatistician1, Justin Thielman, MSc candidate1, Douglas G Altman, professor4, Allison Hirst, project manager5, John Hoey, retired professor6, Anita Palepu, professor78, Kenneth F Schulz, distinguished scientist9, David Moher, senior scientist
To Screen or Not for AF: Is That the Question?
Seemant Chaturvedi, MD
Is the Obesity Paradox a Valid Concept for Stroke?
Seemant Chaturvedi, MD
Does Pregnancy Increase the Risk for Brain AVM Rupture?
Hooman Kamel, MD
Significant Improvement in Door-to-Needle Times and Clinical Outcomes with “Target: Stroke”
Anthony S. Kim, MD, MAS
New Quality Measures for Distal Symmetric Neuropathy Care
Peter James Dyck, MD
It's Not Just the Placebo Effect We Have to Worry About: Introducing Lessebo
Michael S. Okun, MD
Quantifying the Benefits of Faster Onset-to-Treatment Times for Thrombolysis
Anthony S. Kim, MD, MAS
Jonathan Silver, MD
